Unknown

Dataset Information

0

Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis.


ABSTRACT: Genome engineering in human pluripotent stem cells (hPSCs) holds great promise for biomedical research and regenerative medicine. Recently, an RNA-guided, DNA-cleaving interference pathway from bacteria [the type II clustered, regularly interspaced, short palindromic repeats (CRISPR)-CRISPR-associated (Cas) pathway] has been adapted for use in eukaryotic cells, greatly facilitating genome editing. Only two CRISPR-Cas systems (from Streptococcus pyogenes and Streptococcus thermophilus), each with their own distinct targeting requirements and limitations, have been developed for genome editing thus far. Furthermore, limited information exists about homology-directed repair (HDR)-mediated gene targeting using long donor DNA templates in hPSCs with these systems. Here, using a distinct CRISPR-Cas system from Neisseria meningitidis, we demonstrate efficient targeting of an endogenous gene in three hPSC lines using HDR. The Cas9 RNA-guided endonuclease from N. meningitidis (NmCas9) recognizes a 5'-NNNNGATT-3' protospacer adjacent motif (PAM) different from those recognized by Cas9 proteins from S. pyogenes and S. thermophilus (SpCas9 and StCas9, respectively). Similar to SpCas9, NmCas9 is able to use a single-guide RNA (sgRNA) to direct its activity. Because of its distinct protospacer adjacent motif, the N. meningitidis CRISPR-Cas machinery increases the sequence contexts amenable to RNA-directed genome editing.

SUBMITTER: Hou Z 

PROVIDER: S-EPMC3785731 | biostudies-literature | 2013 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis.

Hou Zhonggang Z   Zhang Yan Y   Propson Nicholas E NE   Howden Sara E SE   Chu Li-Fang LF   Sontheimer Erik J EJ   Thomson James A JA  

Proceedings of the National Academy of Sciences of the United States of America 20130812 39


Genome engineering in human pluripotent stem cells (hPSCs) holds great promise for biomedical research and regenerative medicine. Recently, an RNA-guided, DNA-cleaving interference pathway from bacteria [the type II clustered, regularly interspaced, short palindromic repeats (CRISPR)-CRISPR-associated (Cas) pathway] has been adapted for use in eukaryotic cells, greatly facilitating genome editing. Only two CRISPR-Cas systems (from Streptococcus pyogenes and Streptococcus thermophilus), each with  ...[more]

Similar Datasets

| S-EPMC4074098 | biostudies-literature
| S-EPMC7656785 | biostudies-literature
| S-EPMC4609032 | biostudies-literature
| S-EPMC6096830 | biostudies-literature
| S-EPMC4786937 | biostudies-literature
| S-EPMC4230761 | biostudies-other
| S-EPMC8753361 | biostudies-literature
| S-EPMC4809784 | biostudies-literature